Is There More To The Story Than TTK Healthcare's (NSE:TTKHLTCARE) Earnings Growth?
Broadly speaking, profitable businesses are less risky than unprofitable ones. However, sometimes companies receive a one-off boost (or reduction) to their profit, and it's not always clear whether statutory profits are a good guide, going forward. This article will consider whether TTK Healthcare's (NSE:TTKHLTCARE) statutory profits are a good guide to its underlying earnings.
We like the fact that TTK Healthcare made a profit of ₹333.1m on its revenue of ₹5.78b, in the last year. Happily, it has grown both its profit and revenue over the last three years (though we note its revenue is down over the last year).
Check out our latest analysis for TTK Healthcare
Not all profits are equal, and we can learn more about the nature of a company's past profitability by diving deeper into the financial statements. So today we'll look at what TTK Healthcare's cashflow, tax benefits and unusual items tell us about the quality of its earnings. Note: we always recommend investors check balance sheet strength. Click here to be taken to our balance sheet analysis of TTK Healthcare.
A Closer Look At TTK Healthcare's Earnings
As finance nerds would already know, the accrual ratio from cashflow is a key measure for assessing how well a company's free cash flow (FCF) matches its profit. In plain english, this ratio subtracts FCF from net profit, and divides that number by the company's average operating assets over that period. This ratio tells us how much of a company's profit is not backed by free cashflow.
Therefore, it's actually considered a good thing when a company has a negative accrual ratio, but a bad thing if its accrual ratio is positive. That is not intended to imply we should worry about a positive accrual ratio, but it's worth noting where the accrual ratio is rather high. Notably, there is some academic evidence that suggests that a high accrual ratio is a bad sign for near-term profits, generally speaking.
For the year to September 2020, TTK Healthcare had an accrual ratio of -0.42. That indicates that its free cash flow quite significantly exceeded its statutory profit. In fact, it had free cash flow of ₹796m in the last year, which was a lot more than its statutory profit of ₹333.1m. TTK Healthcare's free cash flow improved over the last year, which is generally good to see. Having said that it seems that a recent tax benefit and some unusual items have impacted its profit (and this its accrual ratio).
The Impact Of Unusual Items On Profit
Surprisingly, given TTK Healthcare's accrual ratio implied strong cash conversion, its paper profit was actually boosted by ₹75m in unusual items. We can't deny that higher profits generally leave us optimistic, but we'd prefer it if the profit were to be sustainable. When we analysed the vast majority of listed companies worldwide, we found that significant unusual items are often not repeated. And that's as you'd expect, given these boosts are described as 'unusual'. We can see that TTK Healthcare's positive unusual items were quite significant relative to its profit in the year to September 2020. As a result, we can surmise that the unusual items are making its statutory profit significantly stronger than it would otherwise be.
An Unusual Tax Situation
In addition to the notable accrual ratio, we can see that TTK Healthcare received a tax benefit of ₹136m. This is of course a bit out of the ordinary, given it is more common for companies to be paying tax than receiving tax benefits! The receipt of a tax benefit is obviously a good thing, on its own. However, the devil in the detail is that these kind of benefits only impact in the year they are booked, and are often one-off in nature. In the likely event the tax benefit is not repeated, we'd expect to see its statutory profit levels drop, at least in the absence of strong growth. While we think it's good that the company has booked a tax benefit, it does mean that there's every chance the statutory profit will come in a lot higher than it would be if the income was adjusted for one-off factors.
Our Take On TTK Healthcare's Profit Performance
Summing up, TTK Healthcare's accrual ratio suggests that its statutory earnings are well matched by free cash flow while its unusual items and tax benefit is boosted profit in a way that may not be sustained. For the reasons mentioned above, we think that a perfunctory glance at TTK Healthcare's statutory profits might make it look better than it really is on an underlying level. If you'd like to know more about TTK Healthcare as a business, it's important to be aware of any risks it's facing. Case in point: We've spotted 4 warning signs for TTK Healthcare you should be mindful of and 1 of these bad boys can't be ignored.
Our examination of TTK Healthcare has focussed on certain factors that can make its earnings look better than they are. And, on that basis, we are somewhat skeptical. But there is always more to discover if you are capable of focussing your mind on minutiae. Some people consider a high return on equity to be a good sign of a quality business. So you may wish to see this free collection of companies boasting high return on equity, or this list of stocks that insiders are buying.
If you’re looking to trade TTK Healthcare, open an account with the lowest-cost* platform trusted by professionals, Interactive Brokers. Their clients from over 200 countries and territories trade stocks, options, futures, forex, bonds and funds worldwide from a single integrated account. Promoted
Valuation is complex, but we're here to simplify it.
Discover if TTK Healthcare might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.
Access Free AnalysisThis article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
*Interactive Brokers Rated Lowest Cost Broker by StockBrokers.com Annual Online Review 2020
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com.
About NSEI:TTKHLTCARE
TTK Healthcare
Engages in the animal welfare and human pharma product, consumer product, medical device, protective device, food, and other businesses in India.
Excellent balance sheet with acceptable track record.